Synthesis of some unusual (1,2,4-oxadiazole)-linked hexenopyranosides and mannopyranosides

Journal of Carbohydrate Chemistry

Volumn 27, Issue 4, 2008, Pages 258-277

  Dos Anjos, Janaína Versiani ^a   Sinou, Denis ^a   Srivastava, Rajendra M ^b   Do Nascimento, Silene Carneiro ^b   De Melo, Sebastião J ^b  

^a UNIVERSITÉ LYON 1   (France)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

1,2,4 Oxadiazole based carbohydrate; Cu catalyst; Hexenopyranoside; Mannopyranoside; 3+2 Cycloaddition

Indexed keywords

EID: 46349100541     PISSN: 07328303     EISSN: 15322327     Source Type: Journal    
DOI: 10.1080/07328300802120901     Document Type: Article

References (51)

1. (a) Clapp, L.B. 1,2,4-Oxadiazoles. In Comprehensive Heterocyclic Chemistry, 1st edn.; Potts, K.T., Ed.; Pergamon Press: Oxford, 1984; Vol. 6, 365-392;
2. (b) Jochims, J.C. 1,2,4-Oxadiazoles. In Comprehensive Heterocyclic Chemistry, 2nd edn.; Katritzky, A.R., Rees, C.W., Scriven, E.F.V., Eds.; Pergamon Press: Oxford, 1996; Vol. 4, 179-228;
3. (c) Clapp, L.B. 1,2,4-Oxadiazoles. Adv. Heterocycl. Chem. 1976, 20, 65-116;
4. (d) Hemming, K. Recent developments in the synthesis, chemistry and applications of the fully unsaturated 1,2,4-oxadiazoles. J. Chem. Res. Synop. 2001, 209-216;
5. (e) Kayukova, L.A. Synthesis of 1,2,4-oxadiazoles. Pharm. Chem. J. 2005, 39, 539-547.
6. (a) Borg, S.; Estenne-Boutohou, G.; Luthman, K.; Csoregh, I.; Hesselink, W.; Hacksell, U. Synthesis of 1,2,4-oxadiazole-derived, 1,3,4-oxadiazole- derived, and 1,2,4-triazole- derived dipeptidomimetics. J. Org. Chem. 1995, 60, 3112-3120;
7. (b) Borg, S.; Vollinga, R.C.; Labarre, M.; Payza, K.; Terenius, L.; Luthman, K. Design, synthesis, and evaluation of Phe-Gly mimetics: Heterocyclic building blocks for pseudopeptides. J. Med. Chem. 1999, 42, 4331-4342;
8. (c) Andersen, K.E.; Lundt, B.F.; Jørgensen, A.S.; Braestrup, C. Oxadiazoles as bioisosteric transformations of carboxylic functionalities. 2. Eur J. Med. Chem. 1996, 31, 417-425;
9. (d) Vu, C.B.; Corpuz, E.G.; Merry, T.J.; Pradeepan, S.G.; Bartlett, C.; Bohacek, R.S.; Botfield, M.C.; Eyermann, C.J.; Lynch, B.A.; MacNeil, I.A.; Ram, M.K.; van Schravendijk, M.R.; Violette, S.; Sawyer, T.K. Discovery of potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70. J. Med. Chem. 1999, 42, 4088-4098;
10. (e) Yu, J.; Zhang, S.; Li, Z.; Lu, W.; Zhou, R.; Liu, Y.; Cai, M. Stereoselective synthesis of 1,2:4,5-di-O-isopropylidene-3-C-(5- phenyl-1,2,4-oxadiazol-3-yl)-β-D-psicopyranose and its X-ray crystallographic analysis. Carbohydr. Res. 2003, 338, 257-261;
11. (f) Jakopin, Z.; Roskar, R.; Dolenc, M.S. Synthesis of 3,5-disubstituted 1,2,4-oxadiazoles as peptidomimetic building blocks. Tetrahedron Lett. 2007, 48, 1465-1468.
12. (a) Nicolaides, D.N.; Fylaktakidou, K.C.; Litinas, K.E.; Hadjipavlou-Litina, D. Synthesis and biological evaluation of several coumarin-4-carboxamidoxime and 3-(coumarin-4-yl)-1,2,4-oxadiazole derivatives. Eur. J. Med. Chem. 1998, 33, 715-724;
13. (b) Srivastava, R.M.; Lima, A.D.; Viana, S.S.; da CostaSilva, M.J.; Catanho, M.T.J.A.; de Morais, J.O.F. Antiinflammatory property of 3-aryl-5-(n-propyl) 1,2,4-oxadiazoles and antimicrobial property of 3-aryl-5-(n-propyl)-4,5-dihydro-1,2,4-oxadiazoles: their syntheses and spectroscopic studies. Bioorg. Med. Chem. 2003, 11, 1821-1827.
14. (a) Watjen, F.; Baker, R.; Engelstoff, M.; Herbert, R.; MacLeod, A.; Knight, A.; Merchant, K.; Moseley, J.; Saunders, J.; Swain, C.J.; Wong, E.; Springer, J.P. Novel benzodiazepine receptor partial agonists- oxadiazolylimidazobenzodiazepines. J. Med. Chem. 1989, 32, 2282-2291;
15. (b) Tully,W.R.; Gardner, C.R.; Gillepsie; R. J.; Westwood, R. 2-(Oxadiazolyl)imidazo[1,2-a]pyrimidines and 2-(thiazolyl)imidazo[1,2-a] pyrimidines as agonists and inverse agonists at benzodiazepine receptors. J. Med. Chem. 1991, 34, 2060-2067.
16. (a) Saunders, J.; Cassidy, M.; Freedman, S.B.; Harley, E.A.; Iversen, L.L.; Kneen, C.; MacLeod, A.M.; Merchant, K.J.; Snow, R.J.; Baker, R. Novel quinuclidine-based ligands for the muscarinic cholinergic receptor. J. Med. Chem. 1990, 33, 1128-1138;
17. (b) Street, L.J.; Baker, R.; Book, T.; Kneen, C.O.; MacLeod, A.M.; Merchant, K.J.; Showell, G.A.; Saunders, J.; Herbert, R.H.; Freedman, S.B.; Harley, E.A. Synthesis and biological-activity of 1,2,4-oxadiazole derivatives-highly potent and efficacious agonists for cortical muscarinic receptors. J. Med. Chem. 1990, 33, 2690-2697;
18. (c) Sauerberg, P.; Kindtler, J.W.; Nielsen, L.; Sheardown, M.J.; Honoré, T. Muscarinic cholinergic agonists and anatgonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type-synthesis and structure-activity-relationships. J. Med. Chem. 1991, 34, 687-692;
19. (d) Orlek, B.S.; Blaney, F.E.; Brown, F.; Clark, M.S.G.; Hadley, M.S.; Hatcher, J.; Riley, G.J.; Rosenberg, H.E.;Wadsworth, H.J.; Wyman, P. Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor. J. Med. Chem. 1991, 34, 2726-2735;
20. (e) Macor, J.E.; Ordway, T.; Smith, R.L.; Verhoest, P.R.; Mack, R.A. Synthesis and use of 5-vinyl-1,2,4-oxadiazoles as Michael acceptors. A rapid synthesis of the potent muscarinic agonist L-670, 548. J. Org. Chem. 1996, 61, 3228-3229.
21. 3. J. Med. Chem. 2005, 48, 6169-6173;
22. 1) with high selectivity against all other known S1P receptor subtypes. Bioorg. Med. Chem. Lett. 2006, 16, 3679-3683;
23. 1) with enhanced pharmacokinetic properties. Bioorg. Med. Chem. Lett. 2007, 17, 828-831.
24. 3 receptor antagonists. Bioorg. Med. Chem. Lett. 2006, 16, 839-844.
25. Weidner-Wells, M.A.; Henninger, T.C.; Fraga-Spano, S.A.; Boggs, C.M.; Matheis, M.; Ritchie, D.M.; Argentieri, D.C.; Wachter, M.P.; Hlasta, D.J. Synthesis and structure-activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-1,2,4-oxadiazoles, novel classes of small molecule interleukin-8 (IL-8) receptor antagonists. Bioorg. Med. Chem. Lett. 2004, 14, 4307-4311.
26. Zhang, H.-Z; Kasibhatla, S.; Kuemmerle, J.; Kemnitzer, W.; Ollis-Mason, K.; Qiu, L.; Crogan-Grundy, C.; Tseng, B.; Drewe, J.; Cai, S.X. Discovery and structure-activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents. J. Med. Chem. 2005, 48, 5215-5223.
27. Cottrell, D.M.; Capers, J.; Salem, M.M.; DeLuca-Fradley, K.; Croft, S.L.; Werbovetz, K.A. Antikinetoplastid activity of 3-aryl-5-thiocyanatomethyl-1,2,4- oxadiazoles. Bioorg. Med. Chem. 2004, 12, 2815-2824.
28. Fu, X.; Albermann, C.; Jiang, J.; Liao, J.; Zhang, C.; Thorson, J.S. Antibiotic optimization via in vitro glycorandomization. Nat. Biotechnol. 2003, 21, 1467-1469.
29. (a) Hennen, W.J.; Robins, R.K. Synthesis of 5-(β-D- ribofuranosyl)-1,2,4-oxadiazole-3-carboxamide. J. Heterocycl. Chem. 1985, 22, 1747-1748;
30. (b) Wu, W.D.; Ma, L.T.; Zhang, L.H.; Lu, Y.; Guo, F.; Zheng, Q.T. Synthesis of 5-substituted-3-[(2′S,3′S)-3′- hydroxy-2′-hydroxymethyltetrahydrofuran-3′-yl]-1,2,4-oxadiazoles and their epimers. Tetrahedron Asymm. 2000, 11, 1527-1536.
31. (a) Yu, J.; Zhang, S.; Li, Z.; Lu, W.; Zhang, L.; Zhou, R.; Liu, Y.; Cai, M. Synthesis, X-ray diffraction, and NMR analysis of (2S, 3a′R,6′S,7a′R)-3-acetyl-2′, 2′,2″,2″-tetramethyl-5-phenyl-2,3-dihydro-1,3, 4-oxadiazole-2-spiro-7′-{1′,3′-dioxolano[4,5-c]pyrano} -6′-spiro-4″-(1″,3″-dioxolane). J. Carbohydr. Chem. 2001, 20, 877-884;
32. (b) Benltifa, M.; Vidal, S.; Fenet, B.; Msaddek, M.; Goekjian, P.G.; Praly, J.-P; Brunyàansky, A.; Docsa, T.; Gergely, P. In search of glycogen phosphorylase inhibitors: 5-substituted 3-C-glucopyranosyl-1,2, 4-oxadiazoles from β-D-glucopyranosyl cyanides upon cyclization of O-acylamidoxime intermediates. Eur. J. Org. Chem. 2006, 4242-4256.
33. Srivastava, R.M.; de Freitas Filho, J.R.; da Silva, M.J.; de Melo Souto, S.C.; Carpenter, G.B.; Faustino, W.M. "Synthesis, separation and configuration determination of diastereoisomers of (RS)-1-methyl-3-[3-(aryl)-1, 2,4-oxadiazol-5-yl]propyl 2,3-dideoxy-α-D-erythro-hex-2- enopyranosides". Tetrahedron 2004, 60, 10761-10769.
34. dos Anjos, J.; Sinou, D.; de Melo, S.J.; Srivastava, R.M. Synthesis of glycosyltriazole linked 1,2,4-oxadiazoles. Carbohydr. Res. 2007, 342, 2440-2449.
35. (a) Rostovtsev, V.V.; Green, L.G.; Fokin, V.V.; Sharpless, K.B. A stepwise Huisgen cycloaddition process. Copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angew Chem. Int. Ed. 2002, 41, 2596-2599;
36. (b) Tornoe, C.W.; Christensen, C.; Meldal, M. Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem. 2002, 67, 3057-3064;
37. (c) Wang, Q.; Chittaboina, S.; Barnhill, H.N. Advances in 1,3-dipolar cycloaddition reaction of azides and alkynes - A prototype of "click" chemistry. Lett. Org. Chem. 2005, 2, 293-301;
38. (d) Bock, V.D.; Hiemstra, H.; van Maarseveen, J.H. Cu-I-catalyzed alkyne-azide "click" cycloadditions from a mechanistic and synthetic perspective. Eur. J. Org. Chem. 2006, 51-68;
39. (e) Lutz, J.-F. 1,3-dipolar cycloadditions of azides and alkynes: a universal ligation tool in polymer and materials science. Angew. Chem. Int. Ed. 2007, 46, 1018-1025;
40. (f) Wu, P.; Fokin, V.V. Catalytic azide-alkyne cycloaddition: reactivity and applications. Aldrichimica Acta 2007, 40, 7-17.
41. dos Anjos, J.V.; Sinou, D.; de Melo, S.J.; Srivastava, R.M. Synthesis of ethyl 4-O-[4-(1,2,4-oxadiazol-5-yl)phenyl]-α-D- mannopyranosides. Lett. Org. Chem. 2007, 4, 393-397.
42. Bergmann, E.D.; Bendas, H.; d'Avilla, U. New substances of possible chemotherapeutical value. J. Org. Chem. 1953, 18, 64-69.
43. Lee, B.-Y.; Park, S.R.; Jeon, H.B.; Kim, K.S. A new solvent system for efficient synthesis of 1,2,3-triazoles. Tetrahedron Lett. 2006, 47, 5105-5109.
44. de Oliveira, R.N.; Sinou, D.; Srivastava, R.M. Efficient synthesis of some unsaturated [1,2,3]-triazole-linked glycoconjugates. J. Carbohydr. Chem. 2006, 25, 407-425.
45. de Oliveira, R.N.; Cottier, L.; Sinou, D.; Srivastava, R.M. Stereocontrolled palladium(0)-catalyzed preparation of unsaturated azido-sugars: an easy access to 2- and 4-amino-glycosides. Tetrahedron 2005, 61, 8271-8281.
46. Alley, M.C.; Scudiero, D.A.; Monks, A.; Hursey, M.L.; Czerwinski, M.J.; Fine, D.L.; Abbot, B.J.; Mayo, J.G.; Shoemaker, R.H.; Boyd, M.R. Feasibility of drug screening with panels of human-tumor cell-lines using a microculture tetrazolium assay. Cancer Res. 1988, 48, 589-601.
47. Eagle, H. Propagation in a fluid medium of a human epidermoid carcinoma, strain KB. Proc. Soc. Exper. Biol Med. 1955, 89, 362-364.
48. Eagle, H. Buffer combinations for mammalian cell culture. Science 1971, 174, 500-503.
49. dos Anjos, J.V.; Sinou, D.; de Melo, S.J.; Srivastava, R.M. Synthesis of glycosyltriazole linked 1,2,4-oxadiazoles. Carbohydr. Res. 2007, 342, 2440-2449.
50. Hotha, S.; Tripathi, A. Nobium(V) chloride catalyzed microwave assisted synthesis of 2,3-unsaturated O-glycosides by the Ferrier reaction. Tetrahedron Lett. 2005, 46, 4555-4558.
51. Mosmann, T. Rapid colorimetric assay for cellular growth and survival-application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.